Low Body Mass Index without Malnutrition Is an Independent Risk Factor for Major Cardiovascular Events in Patients

Takuya Kishi1, Akira Kitajima1,2, Kohei Yamanouchi1

  • 1International University of Health and Welfare Graduate School of Medicine.

Insights

Low body mass index (BMI) under 18.5, without malnutrition, may be an independent risk factor for major cardiovascular events (MACE) in hemodialysis patients. This finding highlights a critical area for intervention in this vulnerable population.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Major cardiovascular events (MACE) are a leading cause of morbidity and mortality in patients undergoing hemodialysis.
  • Identifying modifiable risk factors for MACE is crucial for improving patient outcomes in chronic kidney disease populations.

Purpose of the Study:

  • To investigate the risk factors associated with MACE in patients undergoing maintenance hemodialysis.
  • To explore the association between body mass index (BMI) and MACE in this patient cohort.

Main Methods:

  • Retrospective analysis of 132 hemodialysis patients over a 3-year follow-up period (June 2017 - June 2020).
  • Data collection included incidence of MACE (cardiac death, myocardial infarction, revascularization, heart failure hospitalization, stroke) and clinical indicators.
  • Statistical analysis included univariate and multivariable logistic regression to identify independent risk factors for MACE.

Main Results:

  • A total of 31 patients (23.5%) experienced MACE during the study period.
  • Patients with MACE had a significantly lower BMI (< 18.5), longer duration of dialysis, and a history of gastrointestinal bleeding.
  • Multivariable analysis identified BMI < 18.5 as an independent risk factor for MACE, even in the absence of malnutrition markers.

Conclusions:

  • A low BMI (< 18.5) is a significant independent risk factor for major cardiovascular events in hemodialysis patients.
  • This finding suggests that maintaining an adequate BMI may be important for cardiovascular health in patients on hemodialysis.
  • Further prospective studies are warranted to confirm these findings and explore potential underlying mechanisms.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
102
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
146
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
71
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
44